Senate LDA lobbying filing
PFIZER INC.
Reported income
not reported
Reported expenses
$2.87M
Tracked program mentions2
Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.
Vaccine Policy, Coverage and Access HR 4317 - PMB Reform Act of 2025 Gavi Vaccines Alliance Issues HR 2214 - DRUG Act…
- Making, Maintaining, Supply Chain and Logistics0602025Ematched: “Supply|Chain”matched 2+ title words
International Supply Chain Global Access Most Favored Nation Policies Tariffs Non-Tariff Trade Barriers United…
Lobbying activities3
Health IssuesHCR
Vaccine Policy, Coverage and Access HR 4317 - PMB Reform Act of 2025 Gavi Vaccines Alliance Issues HR 2214 - DRUG Act S 832 - EPIC Act of 2025 S 864 - HELP Copays ACT S 882 - Patients Before Middlemen Act Prescription Drug-Use-Related Software (PDURS): Digital Medicine Lyme Disease Issues Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients IRA Biosimilars Pause Fix, Biosimilar Legislation H.R. 5256 - 340B Access ACT Inflation Reduction Act (IRA): Orphan Drug Exemption, Pill Penalty, Biosimilar Pause Vaccine Coverage and Access Drug Pricing
Medicare/MedicaidMMM
Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients PBM Reform S 1702 - Access to Prescription Digital Therapeutics Act of 2025 Digital Therapeutics
Trade (domestic/foreign)TRD
International Supply Chain Global Access Most Favored Nation Policies Tariffs Non-Tariff Trade Barriers United States-Mexico-Canada Agreement (USMCA)
Lobbyists8
- ANGELA WILES
- CATHERINE ROBINSON
- ELISSA ALBEN
- EMILY MUELLER
- FRANCISCO CARRILLO
- JENNIFER WALTON
- MATTHEW STROIA
- STEPHEN CLAEYS
Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.